Procurement opportunity for systemic cancer therapy solutions including chemotherapy, immunotherapy, targeted therapy, and related treatment services.
Contract awarded. Originally published 1 months ago.
No single supplier dominates the field.
In this category, The Newcastle Upon Tyne Hospitals NHS Foundation Trust has awarded 14 contracts to 12 suppliers.
Across this category, the most active winners are CARE LINE HOMECARE LIMITED, SPRINGFIELD HOME CARE SERVICES LIMITED, Roche Diagnostics Ltd — the field to beat, or your route in as a partner.
Newcastle upon Tyne Hospitals NHS Foundation Trust is leasing two Fibroscan devices with maintenance for 36 months to support comprehensive liver disease assessment services.
Lease XVIVO XPS Hardware v.1.9 and purchase 12 disposable lung perfusion kits as part of the EVLP launch program.
Supply of Love 2 Shop gift cards for employee long-term service recognition awards.
Procurement opportunity for third-party independent assessment and testing services to provide objective evaluation and verification of products, systems, or processes.
Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.
Innovate UK is offering up to £25.4 million to fund collaborative projects that clinically validate innovative early cancer diagnostic technologies and devices led by UK organisations including at least one SME.
UKHSA seeks supplier information for Doxycycline 10-pack supply through a preliminary market engagement exercise under the Procurement Act 2023.
Suppliers are invited to complete a preliminary market engagement questionnaire about patient diagnostic and monitoring electrodes by 21st September 2026 through eTendersNI.